Hemophilia Pharmacy Management: Steps for Success With Managed Care and Specialty Pharmacy

Click here to download the slides from this symposium.
Thursday, September 18, 2014
12:00 PM - 5:00 PM
Washington Marriot Wardman Park Hotel
Room: Washington 4-5
Washington, DC
Joint Provided/Co-sponsored by the National Hemophilia Foundation, Postgraduate Institute for Medicine, and Impact Education, LLC.

This activity is supported by educational grants from Baxter BioScience, Biogen Idec, Novo Nordisk, Inc., Bayer HealthCare, and CSL Behring.


Hemophilia Pharmacy Management: Steps for Success With Managed Care and Specialty Pharmacy

Hot Topics Include:
- Clinical Updates in Hemophilia Treatment
- Mock Comprehensive Care Team Visit Featuring an Actual Patient
- A Patient's Journey through the Care Process of Various Payer Types with Breakout Rotations
Workshop 1 - Commercial Plan
Workshop 2 - Medicaid Plan
Workshop 3 - Medicare Plan

Held in conjunction with the National Hemophilia Foundation's 66th Annual Meeting, "Nothing about us without us"

Distinguished Faculty Presenters
Jeff Dunn Jeffrey D. Dunn, PharmD, MBA
Senior Vice President
VRx Pharmacy Services, LLC
Margaret Geary Margaret Geary, MA, MBA, MPH, LCSW, CCM
Clinical Hemophilia Social Worker
UMass Memorial Hospital, New England Hemophilia Center
Marc Gilgannon Marc Gilgannon, PT
Lead Therapist
University of Virginia Children's Hospital
John Grossomanides John Grossomanides, RPh
Senior Clinical Pharmacist
Advanced Pharmacy Concepts
John Knispel John W. Knispel, MD, CPE, FACOG
Regional Medical Director
Commercial Products Florida
Humana Inc.
Patrick Lynch Patrick Lynch
A Patient with Hemophilia
Executive Producer, Believe Digi
Jennifer Maahs Jennifer Maahs, RN, PNP, MSN
Nurse Practitioner
Indiana Hemophilia and Thrombosis Center
Steven Pipe Steven W. Pipe, MD
Director, Division of Pediatric Hematology and Oncology
Pediatric Medical Director, Hemophilia and Coagulation Disorders Program
University of Michigan


Who Should Attend?
This activity is designed to meet the educational needs of specialty pharmacists, home health pharmacists, health plan pharmacists, managed Medicaid pharmacists, medical directors, and other health care professionals with an interest in the management of patients with hemophilia.

Statement of Need/Program Overview
Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans and employers in meeting clinical and/or financial goals. This symposium, joint sponsored by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders.

Educational Objectives
After completing this activity, the participant should be better able to:
  • Discuss the impact of hemophilia with and without inhibitors on clinical, economic, and humanistic outcomes
  • Assess current and emerging hemophilia therapies for children and adults, with and without inhibitors
  • Implement the Medical and Scientific Advisory Council (MASAC) Quality of Care Guidelines for the treatment of hemophilia
  • Employ collaborative care strategies and resources, including HTCs, to improve care coordination for health plan patients with hemophilia
  • Recommend hemophilia management policies and protocols to optimize patient outcomes in a managed care and/or specialty pharmacy setting
  • Provide accurate and appropriate counsel as part of the treatment team
Agenda
Thursday, September 18, 2014
12:00 PM - 5:00 PM
Washington Marriot Wardman Park Hotel
Room: Washington 4-5
Washington, DC

12:00-12:30 PM Registration and Lunch
12:30-12:40 PM Introduction and Objectives/Opening Comments
12:40-1:10 PM Clinical Updates in Hemophilia Treatment
1:10-1:55 PM Mock Comprehensive Care Team Visit Featuring an Actual Patient
1:55-2:05 PM Moderated Question and Answer Session
2:05-4:30 PM A Patient's Journey through the Care Process of Various Payer Types
(Breakout Rotations)

Workshop 1 - Commercial Plan
Workshop 2 - Medicaid Plan
Workshop 3 - Medicare Plan
4:30-5:00 PM Closing Session
  - Summary of Key Take-Aways and Work Plans from Breakouts
  - Faculty Panel Roundtable Review of Learning Obectives
  - Moderate Question and Answer Session
  - Post-Activity Assessment and Evaluation


Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hemophilia Foundation, Postgraduate Institute for Medicine, and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 4.5 contact hours (0.45 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - 0809-9999-14-176-L01-P)

Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 4 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Type of Activity: Application

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.


Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Note: There is NO FEE for attending this Special Pre-Conference Symposium. However, if you wish to attend the NHF Annual Meeting sessions from September 18th through September 20th, a registration fee is required.

Pre-registration will close at 12:00 pm on September 16, 2014.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.